Top Markets
#1 ADO Protocol ADO Protocol +193.12%
#2 Islamic Coin Islamic Coin +155.43%
#3 GoPlus Security GoPlus Security +48.69%
#4 GAIB AID GAIB AID +24.67%
#5 Starpower Starpower +17.54%
#6 Chia Chia +15.11%
#7 Casper Network Casper Network +13.73%
#8 Verus Coin Verus Coin +13.56%
#9 o1.exchange o1.exchange +12.82%
#10 Pons Pons +12.26%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rank in Stocks #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Share Price
$0.5099
Last synced: 2024-10-15
Market Cap
$7.60M
Change (1 day)
2.02%
Change (1 year)
0.00%
Country
US
Trade Anew Medical, Inc. (WENA)

Category

Healthcare
Earnings for Anew Medical, Inc. (WENA)
Earnings in Jun 2024 TTM: $114.12K
According to Anew Medical, Inc. latest financial reports the company's current earnings are $114.12K. In 2022 the company made an earning of $1.56M, an increase over its 2021 earnings that were of $-1.11M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Anew Medical, Inc. from 2021 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B 4,622,261.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B 1,709,242.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B 2,633,790.84%
BE